Insider filing · TARS
Seshadri Neervannan
Chief Operating Officer
profile →
Tarsus Pharmaceuticals, Inc.
TARS · Healthcare · 35 filings in 24 months
ticker →
Seshadri Neervannan sold $772K of Tarsus Pharmaceuticals (TARS)
Executed Mar 17, disclosed Mar 19, 2 days later.
Value, as filed
$772K
11,324 sh across 3 lots
Executed
Mar 17
the trade date, as filed
Disclosed
Mar 19
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SNSeshadri Neervannan (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $772K of TARS (11,324 sh across 3 lots, as filed), executed Mar 17.
The name
TARSHealthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Seshadri Neervannan in TARS
TARSSALE
Tarsus Pharmaceuticals, Inc.
$388K4,564 sh × $85.00
Exec Sep 4
Filed Sep 9 · 4:12 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $200K
2,989 sh × $66.75
Exec Mar 20
Filed Mar 24 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $641K
8,366 sh × $76.67
Exec Mar 4
Filed Mar 5 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $363K
7,583 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET